Sign In
Buy LLY
$1,185.71
-6.23 (-0.523%)
At Close: Aug 07, 2026
Eli Lilly, Boehringer Ingelheim's Jardiance gets FDA approval for chronic kidney disease
08:49am, Friday, 22'nd Sep 2023
Eli Lilly & Co. LLY, -3.42% and Boehringer Ingelheim said Friday that the U.S. Food and Drug Administration has approved their blockbuster drug Jardiance, already used for heart failure and diabetes,
Eli Lilly set to dominate obesity drug market into the next decade, analysts say
08:27am, Friday, 22'nd Sep 2023
Eli Lilly & Co. LLY, -3.42% is best positioned to dominate the fast-growing U.S. market for obesity drugs into the 2030s, BMO Capital Markets analysts said in a report late Thursday. Although Novo Nor
The 7 Most Hated Stocks by Institutional Traders
01:03pm, Wednesday, 20'th Sep 2023
While many retail investors are keen to discover which securities the big market players are snapping up, sometimes it's more telling to zero in on the stocks institutional traders are selling. Why? B
Eli Lilly Sues Businesses Over Alleged Sales of Fake Mounjaro Diabetes Drugs
11:40am, Wednesday, 20'th Sep 2023
Eli Lilly & Co. (LLY) sued 10 medical spas, wellness centers, and compounding pharmacies across the U.S. for allegedly selling products that fraudulently claimed to be its popular diabetes drug, Moun
Eli Lilly sues spas and pharmacies over bootlegged Mounjaro
08:02am, Wednesday, 20'th Sep 2023
Eli Lilly has taken legal action against spa owners, wellness centres and pharmacies for unauthorised versions of its best fat-busting drug Mounjaro. Four separate lawsuits have been filed against out
Flee to Healthcare Stocks if Recession Rears its Head?
07:04am, Wednesday, 20'th Sep 2023
If you're looking for a sector that's on sale, look to healthcare. The Health Care Select Sector SPDR Fund NYSEARCA: XLV is down 2.50% in the past month, lagging the S&P 500.
Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug
04:33pm, Tuesday, 19'th Sep 2023
The lawsuits come as Eli Lilly grapples with a shortage of Mounjaro in the U.S. due to skyrocketing demand.
Eli Lilly sues over US sales of bogus Mounjaro for weight loss
03:06pm, Tuesday, 19'th Sep 2023
Eli Lilly on Tuesday said it was suing 10 U.S. medical spas, wellness centers and compounding pharmacies for selling products claiming to contain tirzepatide, the active ingredient in its diabetes dru
Could Ely Lilly Be the Best Pharma Stock to Own Now and Forever?
07:06am, Tuesday, 19'th Sep 2023
Pharmaceutical giant Eli Lilly & Co. NYSE: LLY stock has been on a tear, trading up 57.7% year-to-date (YTD). The company is firing on all cylinders with its leading medications and a highly anticipat
Eli Lilly: A Potential Game Changer For Weight Management And Cardiovascular Health
11:19pm, Wednesday, 13'th Sep 2023
Eli Lilly's stock has performed well in the market, boosted by strong fundamental results and the success of Novo Nordisk's weight loss drug, Wegovy. Wegovy demonstrated a 20% reduction in the risk of
"Blockbuster Status": 3 Bios to Buy and Hold
03:47pm, Wednesday, 13'th Sep 2023
The biotech sector is notorious for its sky-high R&D costs, regulatory hurdles, and lengthy timelines to bring a drug to market. Stock Strategist Andrew Rocco unveils 3 biotech stocks that have broken
NVS vs. LLY: Which Stock Is the Better Value Option?
12:50pm, Tuesday, 12'th Sep 2023
Investors interested in Large Cap Pharmaceuticals stocks are likely familiar with Novartis (NVS) and Eli Lilly (LLY). But which of these two stocks presents investors with the better value opportunity
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
10:35am, Tuesday, 12'th Sep 2023
Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Should You Still Buy the S&P 500's Best-Performing August Stocks?
05:50am, Tuesday, 12'th Sep 2023
Arista Networks stock soared 26% last month as the demand for its cloud-networking technology surged. Eli Lilly's shares jumped 22% with diabetes drug Mounjaro fueling its revenue growth.
Pound for Pound: 3 Buzzworthy Drug Stocks Worth Their Weight in Gold
09:59pm, Monday, 11'th Sep 2023
Weight-loss drugs are taking the U.S. by storm. JPMorgan Chase (NYSE: JPM ) is forecasting that the market for weight-loss medications could reach $100 billion in annual sales.
